Chad Cohen

Cohen is the CFO of Adaptive Biotechnologies, a publicly held Seattle-based company seeking to translate the scale and precision of the adaptive immune system into products to diagnose and treat disease. Cohen also holds an advisory role as operating partner at Cota Capital. Prior to joining Adaptive, Cohen spent more than nine years with Zillow Group where he served as CFO, among other finance roles during his tenure. He has also held positions with Ticketmaster and Ernst & Young. Cohen has extensive board experience and has contributed to the success of Ticketfly, Trupanion, as well as Adaptive before assuming the role of CFO. Cohen will serve as chair of the audit committee on Vacasa’s board of directors.